Tevogen Bio Inc.
(TVGN)
undefined
undefined%
At close: undefined
1.30
-1.20%
After-hours Jan 08, 2025, 07:59 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 |
| Net Income | -67.33K | 4.41M | -15.60M |
| Depreciation & Amortization | n/a | 230.82K | 9.38K |
| Stock-Based Compensation | n/a | 4.58K | 582.41 |
| Other Working Capital | -34.33K | 566.61K | -571.78K |
| Other Non-Cash Items | -2.21M | 8.32M | 10.98M |
| Deferred Income Tax | n/a | n/a | n/a |
| Change in Working Capital | 897.62K | 737.69K | -1.25M |
| Operating Cash Flow | -1.38M | -215.40K | -5.27M |
| Capital Expenditures | n/a | -479.04K | -109.73K |
| Acquisitions | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | -351.90M |
| Sales Maturities Of Investments | n/a | n/a | n/a |
| Other Investing Acitivies | 342.92M | n/a | n/a |
| Investing Cash Flow | 342.92M | -479.04 | -109.73K |
| Debt Repayment | 1.32M | 7.50K | 12.50M |
| Common Stock Repurchased | -342.98M | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a |
| Other Financial Acitivies | n/a | n/a | n/a |
| Financial Cash Flow | -341.66M | 7.50K | 12.50M |
| Net Cash Flow | -120.35K | -215.40K | 7.12M |
| Free Cash Flow | -1.38M | -694.44K | -5.38M |